Market revenue in 2024 | USD 608.3 million |
Market revenue in 2030 | USD 1,276.6 million |
Growth rate | 13.2% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.39% in 2024. Horizon Databook has segmented the Asia Pacific pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The pancreatic cancer treatment market in the Asia-Pacific region is witnessing rapid advancements, with companies such as AstraZeneca, Novartis AG, and Pfizer Inc. driving innovation. For instance, AstraZeneca.
Has been leveraging its expertise in targeted therapies, supported by the increasing adoption of precision medicine, which has seen a growth of nearly 15% in application within oncology in countries such as Japan.
The region’s rising healthcare expenditure, particularly in China and India, has been pivotal in supporting these developments, enabling increased access to advanced therapies across both urban and rural areas.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific pancreatic cancer treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account